


Scenario: Relocation and expansion of a testing service company in Beijing.
Requirements: Replace outdated equipment and expand genetically modified (GM) detection capabilities while controlling costs.
Solution:
After purchasing our real-time fluorescent quantitative PCR instrument in the early stage, the laboratory further procured the full range of Archimed products during relocation to a new site, helping to enhance the overall laboratory testing capabilities. The identification range of homozygous/heterozygous results varies with materials of different genetic backgrounds and needs to be corrected based on actual genetic backgrounds. Archimed achieves precise adaptation of result interpretation standards by setting relative quantification parameters.
Results:
Through analysis of early data, more accurate interpretation standards were established by setting relative quantification algorithm parameters. Excellent craftsmanship greatly avoids inter-instrument variation and ensures outstanding detection consistency. The stable performance of the full product series has won recognition from the testing institution.

